Starfish polysaccharides downregulate metastatic activity through the MAPK signaling pathway in MCF-7 human breast cancer cells

Mol Biol Rep. 2013 Oct;40(10):5959-66. doi: 10.1007/s11033-013-2705-1. Epub 2013 Sep 25.

Abstract

We investigated the effects of starfish (Asterina pectinifera) polysaccharides on metastatic activity in MCF-7 estrogen receptor (ER)-positive human breast cancer cells. In wound healing assay, 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced cell migration was dose-dependently decreased by the starfish polysaccharides (PS). Transcription of aromatase, which catalyzes estrogen synthesis from androgen, was reduced by PS. Also, transcription of TPA-induced cyclooxygenase-2 (COX-2), which enhances breast cancer progression and metastasis via the increase of prostaglandin E2 biosynthesis, was downregulated by the PS in a dose-dependent manner. PS decreased the expression and activity of matrix metalloproteinase (MMP)-9, an important factor in the degradation of basement membrane and extracellular matrix in the metastasis process. In contrast, mRNA expression of tissue inhibitor of matrix metalloproteinase (TIMP)-1, a MMP inhibitor, was increased by 10-120 μg/ml of PS but not that of TIMP-2. We also found that PS reversed the phosphorylations of p38, ERK and JNK but not IκBα and NF-κB. These results demonstrate that PS successfully inhibits PKC-mediated cell migration and metastatic activities in MCF-7 ER-positive human breast cancer cells via downregulation of MMP-9 activity mediated by TIMP-1 upregulation and inhibition of aromatase and COX-2 expression. Also, COX-2 and MMP-9 expressions are attenuated through the inhibition of AP-1 transcription activity via the downregulation of c-Jun expression regulated by p38, ERK and JNK signaling. In conclusion, the present investigation shows that PS may prevent COX-2- and MMP-9-mediated metastatic activities in MCF-7 ER-positive breast cancer cells through the downregulation of MAPK signaling pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aromatase / genetics
  • Aromatase / metabolism
  • Breast Neoplasms / enzymology*
  • Breast Neoplasms / genetics
  • Breast Neoplasms / pathology*
  • Cell Movement / drug effects
  • Cyclooxygenase 2 / metabolism
  • Down-Regulation / drug effects*
  • Female
  • Humans
  • I-kappa B Proteins / metabolism
  • MAP Kinase Signaling System / drug effects*
  • MCF-7 Cells
  • Matrix Metalloproteinase 9 / metabolism
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / metabolism
  • Neoplasm Metastasis
  • Phosphorylation / drug effects
  • Polysaccharides / pharmacology*
  • Starfish / chemistry*
  • Tetradecanoylphorbol Acetate / pharmacology
  • Tissue Inhibitor of Metalloproteinases / metabolism
  • Transcription, Genetic / drug effects

Substances

  • I-kappa B Proteins
  • NF-kappa B
  • NFKBIA protein, human
  • Polysaccharides
  • Tissue Inhibitor of Metalloproteinases
  • NF-KappaB Inhibitor alpha
  • Aromatase
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • MMP9 protein, human
  • Matrix Metalloproteinase 9
  • Tetradecanoylphorbol Acetate